☰

Jane Boddy - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Tree Info Similar researchers PubMed Report error

14/25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Shaida N, Launchbury R, Boddy JL, Jones C, Campo L, Turley H, Kanga S, Banham AH, Malone PR, Harris AL, Fox SB. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. The Prostate. 68: 336-43. PMID 18163427 DOI: 10.1002/pros.20707  0.668
2007 Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. The Prostate. 67: 1091-8. PMID 17477366 DOI: 10.1002/pros.20583  0.695
2007 Boddy J, Haley R, Wharton I, Sami T, Ryan P, Devarajan R. 690 A RETROSPECTIVE AUDIT OF TURP TO ASSESS THE POTENTIAL IMPACT OF GREEN LIGHT LASER SURGERY ON THE DIAGNOSIS OF PROSTATE CANCER European Urology Supplements. 6: 195. DOI: 10.1016/S1569-9056(07)60686-1  0.369
2006 Boddy JL, Gal S, Malone PR, Shaida N, Wainscoat JS, Harris AL. The role of cell-free DNA size distribution in the management of prostate cancer. Oncology Research. 16: 35-41. PMID 16783966 DOI: 10.3727/000000006783981297  0.535
2005 Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR, Harris AL. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clinical Cancer Research. 11: 7658-7663. PMID 16278385 DOI: 10.1158/1078-0432.CCR-05-0460  0.673
2005 Boddy JL, Pike DJ, Al-Hayek S, Shaida N, Malone PR. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer Prostate Cancer and Prostatic Diseases. 8: 349-352. PMID 16010283 DOI: 10.1038/sj.pcan.4500819  0.54
2005 Boddy JL, Gal S, Malone PR, Harris AL, Wainscoat JS. Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 1394-9. PMID 15746038 DOI: 10.1158/1078-0432.CCR-04-1237  0.547
2005 Boddy J, Fox S, Cheng H, Hurley H, Brown P, Malone P, Banham A, Harris A. 885Co-expression of the forkhead transcription factor, FOXPI with the androgen receptor in human prostate cancer, support its role as a potential co-regulator of this receptor European Urology Supplements. 4: 224. DOI: 10.1016/S1569-9056(05)80889-9  0.668
2005 Boddy J, Pike D, Al-Hayek S, Malone P. 604An elevated psa which returns to within the normal range prior to biopsy does not exclude the presence of prostate cancer European Urology Supplements. 4: 153. DOI: 10.1016/S1569-9056(05)80608-6  0.525
2005 Boddy JL, Fox SB, Cheng H, Hurley H, Brown P, Malone PR, Harris AL. 237: Expression of the Androgen Receptor in Prostate Cancer is related to Vascular Endothelial Growth Factor and Hypoxia Inducible Factors 1: and 2 Journal of Urology. 173: 65-65. DOI: 10.1016/s0022-5347(18)34502-6  0.702
2004 Boddy JL, Dev S, Pike DJ, Malone PR. Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies Bju International. 93: 735-738. PMID 15049982 DOI: 10.1111/j.1464-410X.2003.04717.x  0.466
2004 Boddy J, Gal S, Harris A, Wainscoat J, Malone P. 85 The diagnostic value of cell free DNA levels in prostate cancer and a reminder on the importance of sample selection European Urology Supplements. 3: 24. DOI: 10.1016/S1569-9056(04)90087-5  0.545
2003 Boddy JL, Pike DJ, Malone PR. A seven-year follow-up of men following a benign prostate biopsy European Urology. 44: 17-20. PMID 12814670 DOI: 10.1016/S0302-2838(03)00205-7  0.45
2003 Boddy J, Gal S, Malone P, Harris A, Wainscoat J. Investigating the relationship between plasma DNA levels and prostate cancer European Urology Supplements. 2: 84. DOI: 10.1016/S1569-9056(03)90445-3  0.549
Low-probability matches (unlikely to be authored by this person)
2010 Mak D, Boddy J, Bhardwaj V, Luscombe C, Wallace D, Doherty A. PSA Follow-Up after Radical Prostatectomy: Are NICE Recommendations Over-Generalised? British Journal of Medical and Surgical Urology. 3: 266-266. DOI: 10.1016/J.BJMSU.2010.09.023  0.259
2010 Boddy J, Lai N, Lynch C, Shahzad SA, Doherty AP, Wallace DMA, Bhatt RI. The role of active surveillance in the management of early prostate cancer and the impact of the NICE guidelines British Journal of Medical and Surgical Urology. 3: 101-105. DOI: 10.1016/j.bjmsu.2009.12.003  0.188
2011 Mak D, Boddy J, Vishal V, Luscombe C, Doherty A. 745 ULTRASENSITIVE PSA SURVEILLANCE AFTER RADICAL PROSTATECTOMY BASED ON RECURRENCE RISK STRATIFICATION European Urology Supplements. 10: 237. DOI: 10.1016/S1569-9056(11)60733-1  0.184
2017 Gurung P, Bhasin S, Hussain S, Sensi H, Prakashkumar Y, Boddy J, Cooke P. Evolution of the Surgical Technique to Improve Functional Outcomes in Robot-Assisted Laparoscopic Prostatectomy (RALP): A Single Centre Experience of Over 500 Cases International Journal of Surgery. 47: S7. DOI: 10.1016/J.IJSU.2017.08.058  0.04
2020 Specker E, Forster M, Brinkmann H, Boddy J, Immelmann B, Goller J, Pelowski M, Rosenberg R, Leder H. Warm, lively, rough? Assessing agreement on aesthetic effects of artworks. Plos One. 15: e0232083. PMID 32401777 DOI: 10.1371/journal.pone.0232083  0.038
2011 Ilie CP, Luscombe CJ, Smith I, Boddy J, Mischianu D, Golash A. Routine day-case laparoscopic pyeloplasty: A paradigm shift? Journal of Endourology. 25: 797-801. PMID 21476860 DOI: 10.1089/end.2010.0486  0.021
2011 Ilie CP, Luscombe CJ, Smith I, Boddy J, Mischianu D, Golash A. Day case laparoscopic nephrectomy Journal of Endourology. 25: 631-634. PMID 21413879 DOI: 10.1089/end.2010.0503  0.02
2010 Ilie C, Luscombe C, Smith I, Boddy J, Mischianu D, Golash A. C67 IS DAY CASE LAPAROSCOPIC NEPHRECTOMY FEASIBLE AND SAFE? European Urology Supplements. 9: 636. DOI: 10.1016/S1569-9056(10)61591-6  0.011
2014 Hanna L, Ubee SS, Boddy J, Cooke PW. Efficacy and complications of intravesical BCG in immunocompromised patients. Bju International. 113: 691-3. PMID 24224546 DOI: 10.1111/bju.12562  0.01
2014 Boddy JL. Early stent removal after pyeloplasty Bju International. 113: 846-847. PMID 24905657 DOI: 10.1111/bju.12734  0.01
2007 Boddy J, Wharton I, Devarajan R, Rane A. 654 A NOVEL ENDOSCOPIC TECHNIQUE FOR THE MANAGEMENT OF THE JUXTA-VESICAL URETER DURING LAPAROSCOPIC NEPHROURETERECTOMY European Urology Supplements. 6: 186. DOI: 10.1016/S1569-9056(07)60651-4  0.01
Hide low-probability matches.